Pharmaceutical promotion and transfer-pricing comparability principles limited disallowances, while uncorroborated search allegations and unsupported ...
Business expenditure substantiation supports scrap credits, statutory payments and expense claims, while depreciation requires proof of actual busines...
The AAAR dismissed the appeal and held that import IGST paid via TR-6 challan is not an admissible document for claiming ITC because a TR-6 is a Treasury payment instrument and not a "bill of entry or any similar document" prescribed under the Customs Act or rules; consequently TR-6 (alone or read with SVB orders/letters) cannot support ITC. A re-assessed bill of entry, however, constitutes a prescribed document under r.36(1)(d) and thus may permit ITC, but such availment is governed by the time-bar in s.16(4) CGST, applied to IGST claims by s.20 IGST Act mutatis mutandis. Appeal dismissed.
The AAAR dismissed the appeal and held that import IGST paid via TR-6 challan is not an admissible document for claiming ITC because a TR-6 is a Treasury payment instrument and not a "bill of entry or any similar document" prescribed under the Customs Act or rules; consequently TR-6 (alone or read with SVB orders/letters) cannot support ITC. A re-assessed bill of entry, however, constitutes a prescribed document under r.36(1)(d) and thus may permit ITC, but such availment is governed by the time-bar in s.16(4) CGST, applied to IGST claims by s.20 IGST Act mutatis mutandis. Appeal dismissed.
Note: It is a system-generated summary and is for quick reference only.